Cancer | | Disease | Target | Xaa-Pro Dipeptidase | | | | | | |
Cancer | | Disease | Target | Egl Nine Homolog 1 | | | | | | |
Cancer | | Disease | Drug | Ancobon (Flucytosine)- FDA | | | | | | |
Cancer | | Disease | Target | Melatonin Receptor Type 1a | | | | | | |
Cancer | | Disease | Target | CCBL1 | | | | | | |
Infection | | Disease | Target | CCBL1 | | | | | | |
Cancer | | Disease | Drug | Drimenin | | | | | | |
Carcinoma | | Disease | Target | Xaa-Pro Dipeptidase | | | | | | |
Carcinoma | | Disease | Target | Egl Nine Homolog 1 | | | | | | |
Carcinoma | | Disease | Target | CCBL1 | | | | | | |
Cancer | | Disease | Target | Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 | | | | | | |
Diabetes | | Disease | Target | Xaa-Pro Dipeptidase | | | | | | |
Diabetes | | Disease | Target | E-Selectin/CD62E | | | | | | |
Depression | | Disease | Target | Melatonin Receptor Type 1a | | | | | | |
Stroke | | Disease | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Stroke | | Disease | Target | E-Selectin/CD62E | | | | | | |
Stroke | | Disease | Target | Melatonin Receptor Type 1a | | | | | | |
Shock | | Disease | Target | Xaa-Pro Dipeptidase | | | | | | |
Hemorrhage | | Disease | Drug | Alprostadil for Injection (Edex)- FDA | | | | | | |
Hemorrhage | | Disease | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Prostate Cancer | | Disease | Target | Egl Nine Homolog 1 | | | | | | |
Prostate Cancer | | Disease | Drug | Ancobon (Flucytosine)- FDA | | | | | | |
CD4 | | Target | Target | Ck-beta-11 | | | | | | |
Meningitis | | Disease | Target | CCBL1 | | | | | | |
Infectious Diseases | | Disease | Target | CCBL1 | | | | | | |
Cervical Cancer | | Disease | Target | Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 | | | | | | |
CD4 | | Target | Target | CTLA-4/Fc | | | | | | |
Platelet Aggregation | | Disease | Drug | Alprostadil for Injection (Edex)- FDA | | | | | | |
Platelet Aggregation | | Disease | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Epidermal Growth Factor Receptor | | Target | Target | Xaa-Pro Dipeptidase | | | | | | |
Thromboembolism | | Disease | Drug | Alprostadil for Injection (Edex)- FDA | | | | | | |
Thromboembolism | | Disease | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Antithrombin | | Target | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Major Depressive Disorder | | Disease | Target | Melatonin Receptor Type 1a | | | | | | |
Conjunctivitis | | Disease | Drug | Azelastine hydrochloride (Optivar)- FDA | | | | | | |
Allergic Rhinitis | | Disease | Drug | Azelastine hydrochloride (Optivar)- FDA | | | | | | |
Itching | | Disease | Drug | Azelastine hydrochloride (Optivar)- FDA | | | | | | |
CCL4 | | Target | Target | CCBL1 | | | | | | |
Muscle Pain | | Disease | Drug | Aldomet (Methyldopa)- FDA | | | | | | |
Alpha-Glucosidase | | Target | Drug | Alglucosidase Alfa (Myozyme)- FDA | | | | | | |
Estrogen Receptor Beta | | Target | Target | Egl Nine Homolog 1 | | | | | | |
ELC | | Target | Target | Ck-beta-11 | | | | | | |
Acyclovir (Zovirax)- FDA | | Drug | Drug | Ancobon (Flucytosine)- FDA | | | | | | |
Accolate (Zafirlukast)- FDA | | Drug | Drug | Alocril (Nedocromil)- FDA | | | | | | |
Alupent (Metaproterenol Sulfate)- FDA | | Drug | Drug | Alocril (Nedocromil)- FDA | | | | | | |
Alomide (Lodoxamide Tromethamine)- FDA | | Drug | Drug | Alocril (Nedocromil)- FDA | | | | | | |
Argatroban (Argatroban Injection)- FDA | | Drug | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Argatroban Injection (Argatroban)- FDA | | Drug | Drug | Alprostadil Injection (Caverject)- FDA | | | | | | |
Dragmacidins | | Drug | Drug | Dragmacidin D | | | | | | |
Azelastine Hydrochloride (Astelin)- FDA | | Drug | Drug | Astelin (Azelastine Hydrochloride)- FDA | | | | | | |